The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hemostat Powder-Global Market Insights and Sales Trends 2025

Hemostat Powder-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1826332

No of Pages : 104

Synopsis
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
The global Hemostat Powder market size is expected to reach US$ 531.4 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hemostat Powder in various end use industries. The expanding demands from the Surgical Wound Care and General Wound Care, are propelling Hemostat Powder market. Gelatin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fibrin segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostat Powder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostat Powder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostat Powder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostat Powder sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostat Powder covered in this report include Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox and Equimedical, etc.
The global Hemostat Powder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP
Global Hemostat Powder market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostat Powder market, Segment by Type:
Gelatin
Fibrin
Cellulose
Others
Global Hemostat Powder market, by Application
Surgical Wound Care
General Wound Care
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostat Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Hemostat Powder Market Overview
1.1 Hemostat Powder Product Overview
1.2 Hemostat Powder Market Segment by Type
1.2.1 Gelatin
1.2.2 Fibrin
1.2.3 Cellulose
1.2.4 Others
1.3 Global Hemostat Powder Market Size by Type
1.3.1 Global Hemostat Powder Market Size Overview by Type (2018-2029)
1.3.2 Global Hemostat Powder Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hemostat Powder Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemostat Powder Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hemostat Powder Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hemostat Powder Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hemostat Powder Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hemostat Powder Sales Breakdown by Type (2018-2023)
2 Global Hemostat Powder Market Competition by Company
2.1 Global Top Players by Hemostat Powder Sales (2018-2023)
2.2 Global Top Players by Hemostat Powder Revenue (2018-2023)
2.3 Global Top Players by Hemostat Powder Price (2018-2023)
2.4 Global Top Manufacturers Hemostat Powder Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostat Powder Market Competitive Situation and Trends
2.5.1 Hemostat Powder Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostat Powder Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostat Powder as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostat Powder Market
2.8 Key Manufacturers Hemostat Powder Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostat Powder Status and Outlook by Region
3.1 Global Hemostat Powder Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemostat Powder Historic Market Size by Region
3.2.1 Global Hemostat Powder Sales in Volume by Region (2018-2023)
3.2.2 Global Hemostat Powder Sales in Value by Region (2018-2023)
3.2.3 Global Hemostat Powder Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hemostat Powder Forecasted Market Size by Region
3.3.1 Global Hemostat Powder Sales in Volume by Region (2024-2029)
3.3.2 Global Hemostat Powder Sales in Value by Region (2024-2029)
3.3.3 Global Hemostat Powder Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemostat Powder by Application
4.1 Hemostat Powder Market Segment by Application
4.1.1 Surgical Wound Care
4.1.2 General Wound Care
4.2 Global Hemostat Powder Market Size by Application
4.2.1 Global Hemostat Powder Market Size Overview by Application (2018-2029)
4.2.2 Global Hemostat Powder Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hemostat Powder Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostat Powder Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hemostat Powder Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hemostat Powder Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hemostat Powder Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hemostat Powder Sales Breakdown by Application (2018-2023)
5 North America Hemostat Powder by Country
5.1 North America Hemostat Powder Historic Market Size by Country
5.1.1 North America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemostat Powder Sales in Volume by Country (2018-2023)
5.1.3 North America Hemostat Powder Sales in Value by Country (2018-2023)
5.2 North America Hemostat Powder Forecasted Market Size by Country
5.2.1 North America Hemostat Powder Sales in Volume by Country (2024-2029)
5.2.2 North America Hemostat Powder Sales in Value by Country (2024-2029)
6 Europe Hemostat Powder by Country
6.1 Europe Hemostat Powder Historic Market Size by Country
6.1.1 Europe Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemostat Powder Sales in Volume by Country (2018-2023)
6.1.3 Europe Hemostat Powder Sales in Value by Country (2018-2023)
6.2 Europe Hemostat Powder Forecasted Market Size by Country
6.2.1 Europe Hemostat Powder Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemostat Powder Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemostat Powder by Region
7.1 Asia-Pacific Hemostat Powder Historic Market Size by Region
7.1.1 Asia-Pacific Hemostat Powder Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemostat Powder Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hemostat Powder Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hemostat Powder Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostat Powder Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemostat Powder Sales in Value by Region (2024-2029)
8 Latin America Hemostat Powder by Country
8.1 Latin America Hemostat Powder Historic Market Size by Country
8.1.1 Latin America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemostat Powder Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hemostat Powder Sales in Value by Country (2018-2023)
8.2 Latin America Hemostat Powder Forecasted Market Size by Country
8.2.1 Latin America Hemostat Powder Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemostat Powder Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemostat Powder by Country
9.1 Middle East and Africa Hemostat Powder Historic Market Size by Country
9.1.1 Middle East and Africa Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemostat Powder Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hemostat Powder Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hemostat Powder Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostat Powder Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemostat Powder Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Hemostat Powder Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 C. R. Bard
10.2.1 C. R. Bard Company Information
10.2.2 C. R. Bard Introduction and Business Overview
10.2.3 C. R. Bard Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.2.4 C. R. Bard Hemostat Powder Products Offered
10.2.5 C. R. Bard Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Hemostat Powder Products Offered
10.3.5 Pfizer Recent Development
10.4 CSL Behring
10.4.1 CSL Behring Company Information
10.4.2 CSL Behring Introduction and Business Overview
10.4.3 CSL Behring Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CSL Behring Hemostat Powder Products Offered
10.4.5 CSL Behring Recent Development
10.5 Gelita Medical
10.5.1 Gelita Medical Company Information
10.5.2 Gelita Medical Introduction and Business Overview
10.5.3 Gelita Medical Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Gelita Medical Hemostat Powder Products Offered
10.5.5 Gelita Medical Recent Development
10.6 Ferrosan Medical Devices
10.6.1 Ferrosan Medical Devices Company Information
10.6.2 Ferrosan Medical Devices Introduction and Business Overview
10.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ferrosan Medical Devices Hemostat Powder Products Offered
10.6.5 Ferrosan Medical Devices Recent Development
10.7 Baxter
10.7.1 Baxter Company Information
10.7.2 Baxter Introduction and Business Overview
10.7.3 Baxter Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Baxter Hemostat Powder Products Offered
10.7.5 Baxter Recent Development
10.8 Celox
10.8.1 Celox Company Information
10.8.2 Celox Introduction and Business Overview
10.8.3 Celox Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Celox Hemostat Powder Products Offered
10.8.5 Celox Recent Development
10.9 Equimedical
10.9.1 Equimedical Company Information
10.9.2 Equimedical Introduction and Business Overview
10.9.3 Equimedical Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Equimedical Hemostat Powder Products Offered
10.9.5 Equimedical Recent Development
10.10 Medira
10.10.1 Medira Company Information
10.10.2 Medira Introduction and Business Overview
10.10.3 Medira Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medira Hemostat Powder Products Offered
10.10.5 Medira Recent Development
10.11 Biocer
10.11.1 Biocer Company Information
10.11.2 Biocer Introduction and Business Overview
10.11.3 Biocer Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Biocer Hemostat Powder Products Offered
10.11.5 Biocer Recent Development
10.12 Hemostasis
10.12.1 Hemostasis Company Information
10.12.2 Hemostasis Introduction and Business Overview
10.12.3 Hemostasis Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hemostasis Hemostat Powder Products Offered
10.12.5 Hemostasis Recent Development
10.13 MBP
10.13.1 MBP Company Information
10.13.2 MBP Introduction and Business Overview
10.13.3 MBP Hemostat Powder Sales, Revenue and Gross Margin (2018-2023)
10.13.4 MBP Hemostat Powder Products Offered
10.13.5 MBP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostat Powder Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostat Powder Industrial Chain Analysis
11.4 Hemostat Powder Market Dynamics
11.4.1 Hemostat Powder Industry Trends
11.4.2 Hemostat Powder Market Drivers
11.4.3 Hemostat Powder Market Challenges
11.4.4 Hemostat Powder Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostat Powder Distributors
12.3 Hemostat Powder Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’